APA

Schwartz G. K., Tap W. D., Qin L., Livingston M. B., Undevia S. D., Chmielowski B., Agulnik M., Schuetze S. M., Reed D. R., Okuno S. H., Ludwig J. A., Keedy V., Rietschel P., Kraft A. S., Adkins D., Van Tine B. A., Brockstein B., Yim V., Bitas C., Abdullah A., Antonescu C. R., Condy M., Dickson M. A., Vasudeva S. D., Ho A. L., Doyle L. A., Chen H. X. & Maki R. G. (20130704). Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial. : The Lancet. Oncology.

Chicago

Schwartz Gary K, Tap William D, Qin Li-Xuan, Livingston Michael B, Undevia Samir D, Chmielowski Bartosz, Agulnik Mark, Schuetze Scott M, Reed Damon R, Okuno Scott H, Ludwig Joseph A, Keedy Vicki, Rietschel Petra, Kraft Andrew S, Adkins Douglas, Van Tine Brian A, Brockstein Bruce, Yim Vincent, Bitas Christiana, Abdullah Abdul, Antonescu Cristina R, Condy Mercedes, Dickson Mark A, Vasudeva Shyamprasad Deraje, Ho Alan L, Doyle L Austin, Chen Helen X and Maki Robert G. 20130704. Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial. : The Lancet. Oncology.

Harvard

Schwartz G. K., Tap W. D., Qin L., Livingston M. B., Undevia S. D., Chmielowski B., Agulnik M., Schuetze S. M., Reed D. R., Okuno S. H., Ludwig J. A., Keedy V., Rietschel P., Kraft A. S., Adkins D., Van Tine B. A., Brockstein B., Yim V., Bitas C., Abdullah A., Antonescu C. R., Condy M., Dickson M. A., Vasudeva S. D., Ho A. L., Doyle L. A., Chen H. X. and Maki R. G. (20130704). Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial. : The Lancet. Oncology.

MLA

Schwartz Gary K, Tap William D, Qin Li-Xuan, Livingston Michael B, Undevia Samir D, Chmielowski Bartosz, Agulnik Mark, Schuetze Scott M, Reed Damon R, Okuno Scott H, Ludwig Joseph A, Keedy Vicki, Rietschel Petra, Kraft Andrew S, Adkins Douglas, Van Tine Brian A, Brockstein Bruce, Yim Vincent, Bitas Christiana, Abdullah Abdul, Antonescu Cristina R, Condy Mercedes, Dickson Mark A, Vasudeva Shyamprasad Deraje, Ho Alan L, Doyle L Austin, Chen Helen X and Maki Robert G. Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial. : The Lancet. Oncology. 20130704.